Y-90-Daclizumab (HAT)
90Y-labeled humanized anti-Tac (90Y-HAT, 90Y-Daclizumab) is a radiolabeled monoclonal antibody [...]
Y-90-Epratuzumab Tetratexan
90Y-Epratuzumab tetraxetan entered the clinical phase as early as 1996. [...]
Y-90-Ferritarg
Ferritarg is a rabbit polyclonal antibody that is coupled with [...]
I-131-81C6 mAb (Neuradiab™)
131I-81C6 (131I-Monoclonal Antibody 81C6, Neuradiab™) is a radioimmunoconjugate consisting of [...]
I-131-BA52
131I-BA52 is a small molecule, a melanin-binding benzamide, being developed [...]
Lu-177-ST2210 (IART – Lu-177 DOTA-Biotin)
IART® stands for Intraoperative Avidination for Radionuclide Treatment. It is [...]
I-131-TM601
131I-TM601 (131I-Chlorotoxin) is a synthetic radiolabeled peptide with anti-angiogenic activity [...]
Ho-166-Phytate
166Ho-Phytate (Holmium-166-Phytate) was developed as an iv radiotherapeutic for the [...]
Lu-177-Lilotomab Satetraxetan (Betalutin)
Betalutin™ is the brand name of an anti-CD37 antibody labeled [...]
At-211-81C6 mAb (Neuradiab)
211At-81C6-mAb (anti tenascin, human/mouse chimeric antibody) is a radiotherapeutic based [...]